Core Viewpoint - The rapid development and application of artificial intelligence technology have made the research and development of ophthalmic surgical robots a key focus in the industry, aiming to enhance precision and safety in eye surgeries [1][3]. Group 1: Technological Advancements - The Chinese Academy of Sciences' Institute of Automation has successfully developed an autonomous microscopic ophthalmic surgical robot system that has been clinically validated [3]. - This robotic system can autonomously perform subretinal and intravascular injections within the eye, significantly improving the precision, safety, and consistency of fundus injections while minimizing iatrogenic damage [3][4]. Group 2: Research Contributions - The research team has innovatively constructed core algorithm modules for three-dimensional spatial perception, precise cross-scale positioning, and trajectory control during surgeries [4]. - A multi-view spatial fusion method has been proposed to overcome imaging heterogeneity and dynamic spatial misalignment in multimodal intraocular imaging, creating a dynamically updated global 3D map for comprehensive perception of the intraocular region [4]. Group 3: Performance Metrics - In experiments involving retinal and vascular injections in artificial and live animal eyes, the autonomous surgical robot achieved a 100% injection success rate, with average positioning errors reduced by 79.87% compared to manual surgery and 54.61% compared to doctor-assisted robotic surgery [4]. - The research indicates that this development opens a new technological pathway for the autonomy of intraocular surgeries, potentially leading to intelligent and precise upgrades in ophthalmic surgical treatments [4].
【中国新闻网】中国团队成功研发自主显微眼科手术机器人系统 已验证临床可行性